The Guardian (March 21): About 80% of people who get Covid-19 experience a mild case [WHO said the same] – about as serious as a regular cold – and recover without needing any special treatment.
There have been over 11,000 deaths globally....estimates of the mortality rate have ranged from well below 1% in the young to over 3% among those who are elderly or have underlying health conditions. Seasonal flu typically has a mortality rate below 1% and is thought to cause about 400,000 deaths each year globally. Sars had a death rate of more than 10%.
USA News (March 5): Some people don't have any symptoms at all. About 80% of people recover from the disease without needing special treatment,
NPR: (March 20,) "at least one-quarter to... 81% of the U.S. population could get infected....COVID-19 is currently estimated to kill at least 10 people per thousand infected (1%).
CDC (March 18, ): among patients with COVID-19 in the United States the estimated fatality rate among persons aged 19 years and younger was 0%; 1% among persons aged 20–54 years; 1% to 3% among persons aged 55-64 years, and ranging from 10% to 27% among persons aged 85 and up. 80 percent of US coronavirus deaths are people 65 and older .
NYT (March 19,): Death rate in Wuhan Is Lower than Previously Thought. Researchers calculated a 1.4 percent likelihood of dying in the city where the pandemic began. Earlier estimates ranged from 2 percent to 3.4 percent.
healthline.com: it’s possible another 77,000 people or even more have the virus already in the United States.
>statnews.com (March 17) Three months after the outbreak emerged, most countries, including the U.S., lack the ability to test a large number of people and no countries have reliable data on the prevalence of the virus in a representative random sample of the general population.
The one situation where an entire, closed population was tested was the Diamond Princess cruise ship and its quarantine passengers. The case fatality rate there was 1.0%, but this was a largely elderly population, in which the death rate from Covid-19 is much higher.
Projecting the Diamond Princess mortality rate onto the age structure of the U.S. population, the death rate among people infected with Covid-19 would be 0.125%. But since this estimate is based on extremely thin data — there were just seven deaths among the 700 infected passengers and crew — the real death rate could stretch from five times lower (0.025%) to five times higher (0.625%).
Try selling insurance with those mortality tables to the US and the world.
You'll get some actuarians on your side, but for the rest of the drones, anyone can die.
the die has been cast. It's just time to ride the lightening until it's time to dig ourselves out.
If it's good enough for Climate Change..
National Nightmare: 1 In 5 Americans Expects They’ll Be Diagnosed With Coronavirus
https://www.studyfinds.org/national-nightmare-1-in-5-americans-expect-theyll-be-diagnosed-with-coronavirus/
Alien Anxiety: 1 In 5 Adults Fears Martians Will Invade Earth Within Next 50 Years
https://www.studyfinds.org/wp-content/uploads/2020/03/alien-4868331-816x520.jpg
Yes, “we” are making decisions without reliable data.
We have no choice, and I’m taking no sides.
Next.
We should know in about two weeks if all of this was overreaction.
The deep state plan is to do mass testing.
The testing will have many false positives.
This means lots of people will be told they have it when they actually don’t have it.
Don’t fall for their plan.
Event 201 Pandemic Exercise: Highlights Reel
nov 2019
https://www.youtube.com/watch?v=AoLw-Q8X174
they modeled this whole thing with a dry run
covid-19 mortality rate estimate bookmark
One of the fallouts of this will be tons of questions about just what the f*** the CDC has been doing with the billions we give them every year.
Ping
They DON’T WANT reliable data.
That might get in the way of forcing their agenda on us.
THis guy might not have all the data but I’m certain President Trump and his team do.
Watching these virus experts is like watching storm chasers in oklahoma. Most are pretty decent people, but they are really hoping for a big storm....
Probably true, but if you say it, people (especially liberals) want to kill you.
That should have happened, but did not. A large number of passengers refused to be tested.
From the link above:
"Only 300 of the passengers at Travis took the test; 545, including the Kilcullens, refused."
Thanks heaps, passengers.
Passengers from the Grand Princess were transferred not just to Travis AFB, but to other locations. I do not know how many of the latter refused to be tested.
Since a possibly substantial portion of patients with COVID-19 show minimal or no signs of illness, I was looking forward to seeing the results of testing from the big cruise ships -- testing that included all passengers. The policy has been: Don't test people who have no signs or symptoms of the disease. There are good reasons for that policy, but it might -- just might -- miss many infected people. One good place to look for such patients was on the Grand Princess. Apparently that opportunity has been lost.
Consider, what are the life and health risks of 15 - 20 - 25 percent unemployment? Alcoholism, drug abuse, spousal/child abuse, child neglect, despair and OPPORTUNITY COST. At some point prevention of spread will be more costly than spread. I don’t think we’re there, but we will be soon.
Ok...so this is going to sound very cruel, but if your over 70 years old you’ve lived. You can’t rob younger generations of prosperity...the young their opportunity. (Besides, you’ve already left them $20 trillion in debt.)
Hate away on me!
Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test
First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19
SUNNYVALE, Calif., March 21, 2020 /PRNewswire/ — Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2, the virus causing COVID-19. The test has been designed to operate on any of Cepheid’s more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes.
“During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities. An accurate test delivered close to the patient can be transformative — and help alleviate the pressure that the emergence of the 2019-nCoV outbreak has put on healthcare facilities that need to properly allocate their respiratory isolation resources,” said Dr. David Persing, MD, Ph.D., Chief Medical and Technology Officer at Cepheid. “By leveraging the design principles of our current Xpert Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted to provide rapid detection of current and potential future variants of SARS-CoV-2, we have developed a test that provides reference lab-quality results in multiple settings where actionable treatment information is needed quickly.”
“Cepheid currently has nearly 5,000 GeneXpert® Systems in the US capable of point-of-care testing and for use in hospitals,” said Cepheid President Warren Kocmond. “Our automated systems do not require users to have specialty training to perform testing — they are capable of running 24/7, with many systems already doing so today.”
The test will begin shipping next week.About Cepheid
Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation’s (NYSE: DHR) Diagnostics platform. Cepheid is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.
For more information about Cepheid’s Xpert Xpress SARS-CoV-2 test, please visit www.cepheid.com/coronavirus. For more information, visit http://www.cepheid.com
That’s what happens when mindless panic reigns...one “less than optimal” decision/action is met by another and inertia of less-than-optimal decisions/actions take over and develops it’s own life.
